Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Operating Leases (2022 - 2026)

Treace Medical Concepts filings provide 4 years of Operating Leases readings, the most recent being $14.0 million for Q4 2025.

  • On a quarterly basis, Operating Leases fell 12.25% to $14.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.0 million, a 12.25% decrease, with the full-year FY2025 number at $14.0 million, down 12.25% from a year prior.
  • Operating Leases hit $14.0 million in Q4 2025 for Treace Medical Concepts, up from $12.9 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $19.0 million in Q3 2022 to a low of $12.9 million in Q3 2025.
  • Median Operating Leases over the past 4 years was $15.9 million (2023), compared with a mean of $15.7 million.
  • Biggest five-year swings in Operating Leases: grew 4.65% in 2024 and later fell 21.57% in 2025.
  • Treace Medical Concepts' Operating Leases stood at $15.5 million in 2022, then rose by 2.27% to $15.9 million in 2023, then increased by 0.27% to $15.9 million in 2024, then fell by 12.25% to $14.0 million in 2025.
  • The last three reported values for Operating Leases were $14.0 million (Q4 2025), $12.9 million (Q3 2025), and $13.4 million (Q2 2025) per Business Quant data.